Karen J Wilson is a director of Elicio Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Elicio Therapeutics, Inc.
29 Dec 23
4
Angion Biomedica Corp.
13 Jun 22
4
Vaxart, Inc.
17 Jun 21
4
Angion Biomedica Corp.
10 Mar 21
4
Angion Biomedica Corp.
11 Feb 21
3
Angion Biomedica Corp.
4 Feb 21
4
Vaxart, Inc.
27 Aug 20
3
Vaxart, Inc.
27 Aug 20
4
Jazz Pharmaceuticals plc
7 Mar 19
4
Jazz Pharmaceuticals plc
4 Mar 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Dec 23 | ELTX Elicio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 8.26 | 4,100 | 33.87 k | 4,100 |